FDA
approval
· 2024-02-14
FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Baxter Healthcare Corporation)
Summary
FDA approved Baxter's original application for pantoprazole sodium in 0.9% sodium chloride. It is a proton pump inhibitor used to treat acid-related disorders.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE)